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Sympathetic activityThe development of sympathetic overactivity andhypertension in rats submitted to chronic intermittent hypoxia
(CIH) involve alterations in the central mechanisms controlling respiratory and autonomic functions. Herein, we
assessed whether CIH alters glutamatergic and/or purinergic signaling in the ventrolateral medulla (VLM), a
region that encompasses thepre-sympathetic neurons and respiratoryneuronsof theventral respiratory column.
Groups of juvenile rats were exposed for 10 days to CIH (6% O2 for 40 s, every 9 min, 8 h/day) or normoxia
(controls). Following treatment, in situ working heart-brainstem preparations were performed to record
simultaneously respiratory and sympathetic motor outputs. In separate CIH and control groups, the VLM was
dissected for western-blot analyses of ionotropic glutamatergic and P2 receptors. L-glutamate microinjections
(1, 3 or 10 mM) into VLM of control (n=6) and CIH groups (n=10) produced similar increases of sympathetic
and abdominal activities associated with phrenic nerve inhibition; immunoreactive NMDAR1 and GluR2/3
densities at the VLM were also alike between groups (n=4). In contrast, VLM microinjections of ATP (1, 10 or
50 mM) evoked larger sympatho-excitatory responses in CIH (n=8) than in control rats (n=7, Pb0.05) whilst
the abdominal increase and phrenic nerve inhibition were of comparable magnitudes. The immunoreactive
densities of P2X3 and P2X4 receptors, but not P2X1 and P2Y2, were 20% higher in VLM of CIH (n=8; Pb0.05)
than controls (n=8). Altogether, our ﬁndings suggest that CIH augments purinergic signaling in the VLM,
supporting the concept that nucleotides play a role in the dynamic central control of the sympathetic autonomic
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Peripheral chemoreceptors, mainly located in the carotid bodies, play
a key role inmonitoring oxygen in the arterial blood and activating neural
mechanisms that evoke respiratory and cardiovascular adjustments in
response to acute hypoxia (Machado, 2001, 2004; Lahiri et al., 2006).
Chronically, the overactivation of peripheral chemoreceptors has been
associated with the development of cardiovascular and respiratory
dysfunctions (Caples et al., 2005; Durán-Cantolla et al., 2009). Such
condition can be observed in patients suffering of obstructive sleep apnea
(OSA), which experience chronic intermittent hypoxia (CIH) due to the
repetitive obstructions of the upper airways during sleep (Dempsey et al.,
2010). Clinical studies show that long-term exposure to episodic hypoxia
is an important risk factor contributing to cardiovascular dysfunctions in
OSA patients, mainly arterial hypertension (Somers, 1995; Leuenberger
et al., 2005). In rats, we demonstrated that the exposure to CIH elicited anincreased basal sympathetic activity, which was determinant to elevate
arterial pressure in theseanimals (Fletcher, 2001;Zoccal et al., 2007, 2008,
2009). These data indicate that alterations in the sympathetic nervous
system contribute to the development of arterial hypertension in CIH
rats. However, the neurochemical mechanisms involved remain to be
established.
A cluster of neurons located in the rostral aspect of ventrolateral
medulla (VLM) that provide excitatory drive to pre-ganglionic neurons
in the spinal cord has been considered pivotal for the generation of
sympathetic activity (Guyenet, 2006). At the same level, and alongwith
the pre-sympathetic VLMneurons, it is also foundpart of the inspiratory
and expiratory neurons of ventral respiratory column (VRC) that play a
dominant role in the generation of respiratory rhythm (Bianchi et al.,
1995; Feldman and Del Negro, 2006; Abdala et al., 2009). It has been
suggested that VRC neurons modulate the pre-sympathetic neuronal
activity and contribute for the generation of the respiratory modulation
of sympathetic activity in normoxic (Haselton and Guyenet, 1989) as
well as in hypoxic conditions (Mandel and Schreihofer, 2009). This
central entrainment between respiratory and sympathetic neurons
appears to be altered in CIH rats. We previously reported that rats
submitted to CIH exhibit an additional burst of activity in sympathetic
nerves phase-locked with the emergence of a novel burst of activity in
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(Zoccal et al., 2008). These data pointed out a strengthened interaction
between sympathetic and expiratory neurons in CIH rats, not seen in
controls, suggesting that alterations in the neurochemical mechanisms
underlying central respiratory–sympathetic coupling at the VLM
contributes to the increased sympathetic activity observed after CIH
(Zoccal et al., 2009).
L-glutamate is a major excitatory transmitter released in the VLM
after the activation of peripheral chemoreceptors, leading to the
excitation of pre-sympathetic (Sun and Reis, 1995) and respiratory
neurons (Richter et al., 1999). However, within the past few years, the
role of adenosine-5′-triphosphate (ATP) in the VLM has been
recognized and thought to play an increasingly interesting function
(Rong et al., 2003; Gourine et al., 2005, 2010; Huxtable et al., 2010). In
hypoxia, the processing of tachypneic reﬂex response involves the
release of ATP at the VLM level, speciﬁcally in an area encompassing
the respiratory neurons of the Bötzinger and pre-Bötzinger complexes
as well the neurons of the retrotrapezoid nucleus (Gourine et al.,
2005). Moreover, ATP microinjections in the VLM produced an
increase of arterial pressure mediated by P2X receptor activation,
suggesting an excitatory effect of ATP on pre-sympathetic neurons of
VLM (Thomas et al., 2001). Thereby, as far as both glutamatergic and
purinergic systems are relevant for chemoreﬂex responses processing,
we explored possible changes in glutamatergic or purinergic signaling
in the VLM of rats submitted to CIH. We evaluated the sympathetic
and respiratory responses to exogenous L-glutamate or ATP applica-
tions and assessed by western blot analysis the immunoreactivity of
ionotropic glutamatergic and some P2X and P2Y receptors in the VLM
of rats exposed to CIH and their matched paired controls. The present
results indicate that the sympatho-excitatory responses to ATP,
but not L-glutamate, is increased in CIH rats, a ﬁnding paralleled
by a 20% increase in P2X3 and P2X4, but not P2X1 or P2Y2 receptor
immunoreactivity in the VLM.
2. Methods
2.1. Animals and ethical committee approval
JuvenilemaleWistar rats (19–21 days)obtained fromtheAnimal Care
Facility of the University of São Paulo at Ribeirão Preto, Brazil, were
divided in two experimental groups: those exposed to chronic intermit-
tent hypoxia (CIH group, n=39) and the matched normoxia controls
(control group, n=35). All experimental protocols were approved by
local Ribeirão Preto Ethical Committee on Animal Experimentation of the
School of Medicine of Ribeirão Preto (protocol 019/2006).
2.2. Procedure for the chronic intermittent hypoxia
The CIH and control groups of rats were housed in collective cages
and maintained in Plexiglas chambers (volume, 210 L) equipped with
gas injectors and O2, CO2, humidity and temperature sensors. The CIH
groupwas exposed to 5 min of normoxia (fraction of inspired O2, FiO2,
of 20.8%) followed by 4 min of N2 injection to reduce FiO2 to 6%. After
30–40 s of hypoxia, O2 was injected to return FiO2 back to 20.8%. This
9-min cycle was repeated 8 h a day (from 9.30 am to 5.30 pm) for
10 days. During the remaining 16 h, the animals were exposed to
20.8% FiO2. The injections of N2 and O2 (White Martins, Sertãozinho,
Brazil) were regulated by a solenoid valve system whose opening–
closing control was operated by a computerized system (Oxycycler,
Biospherix, New York, USA). In the same room, in a side-by-side
identical chamber, the control rats were exposed to 20.8% FiO2 24 h a
day for 10 days. The control rats were also exposed to a similar valve
noise as that experienced by the CIH group, except that FiO2 was
maintained at 20.8%. Gas injections were delivered through the upper
part of the chambers, to avoid stress due to direct jets of gas that could
impact on the animals.2.3. In situ arterially-perfused preparation
Working heart–brainstem preparations from control (n=11) and
CIH rats (n=15) were surgically prepared on the 11th day of the
experimental protocol, as previously described (Paton, 1996; Zoccal
et al., 2008). Brieﬂy, rats were deeply anesthetized with halothane
(AstraZeneca do Brazil Ltda., Cotia, SP, Brazil) until loss of the paw
withdrawal reﬂex, transected caudal to the diaphragm, submerged in
a cooled Ringer solution (in mM: NaCl, 125; NaHCO3, 24; KCl, 5; CaCl2,
2.5; MgSO4, 1.25; KH2PO4, 1.25; dextrose, 10) and decerebrated at the
precollicular level. This procedure rendered the rats pain insensible.
Preparations were then transferred to a recording chamber, the
descending aorta was cannulated and perfused retrogradely with
Ringer solution containing 1.25% Ficoll (an oncotic agent) and a
neuromuscular blocker (vecuronium bromide, 3–4 μg/ml, Cristália
Produtos Químicos Farmacêuticos Ltda, São Paulo, Brazil), using a
roller pump (Watson-Marlow 502 s, Falmouth, Cornwall, UK) via a
double-lumen cannula. The perfusion pressure was maintained in the
range of 50–70 mm Hg by adjusting the ﬂow between 21 and 25 ml/
min and by adding 600–1200 pM of vasopressin to the perfusate. The
perfusate was continuously gassed with 5% CO2 and 95% O2 (White
Martins, Sertãozinho, Brazil), warmed to 31–32 °C (temperature
measured at the point of entry into the aorta) and ﬁltered using a
nylon mesh (pore size: 25 μm, Millipore, Billirica, MA, USA).
2.4. Nerve recordings and data analyses
Cardiorespiratory motor nerves were isolated and recorded simul-
taneously using bipolar glass suction electrodes held in micromanipu-
lators (Narishige, Tokyo, Japan). Left phrenic nerve (PN) discharges
were recorded from its central end and its rhythmic ramping activity
was used as a continuous physiological index of preparation viability.
The efferent activity of the left thoracic sympathetic nerve (tSN) was
recorded from the sympathetic chain at T8–T12 level. An abdominal
nerve (Abd) was isolated from the abdominal muscles on the right at
lumbar level, cut distally and its efferent activity recorded. All the signals
were ampliﬁed, band-pass ﬁltered (0.5–5 kHz) and acquired in an A/D
converter (CED micro 1401, Cambridge Electronic Design, CED,
Cambridge, UK) to a computer using Spike 2 software (5 kHz, CED).
The frequency of phrenic discharges was determined by the time
interval between consecutive integrated phrenic peak bursts. Thoracic
sympathetic and abdominal nerve activities were assessed as the area
under the curve. The evoked alterations in all nerve activities were
determined as the percentage of change in relation to the respective
baseline activity prior to the stimulus. All the analyses were carried out
on rectiﬁed and integrated signals (time constant of 50 ms) and
performed off-line using Spike 2 software with custom-written scripts.
2.5. Microinjections into the VLM region
Different concentrations of L-glutamate or ATP were microinjected
into the rostral aspect of VLM of control and CIH in situ preparations,
where the pre-sympathetic VLM neurons are found and the rostral
portion of the ventral respiratory column, mostly expiratory neurons of
Bötzinger complex (BötC) (Sun et al., 1988; Smith et al., 1991; Sun et al.,
1994; Smith et al., 2007). The rostral VLM was approached dorsally
using the following coordinates: 1.2–1.3 mm rostral to calamus
scriptorius, 1.6 lateral to midline and 2.7–2.9 ventral to dorsal surface
of medulla. Microinjections of 1, 3 or 10 mM of L-glutamate (Ito et al.,
2001;Mueller et al., 2011;Moraes et al., in press), and 1, 10 or 50 mMof
ATP (Thomas et al., 2001; Moraes et al., in press), were performed in
separate groups of animals using three-barrel glass pipettes connected
to pico-pump system (Picospritzer II, Parker Instruments, OH, USA). A
time interval of 10–15 min was allowed between consecutive microin-
jections and at each time the volume injected was 20–30 nL.
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At the end of each experiment, 1% Evans Bluewasmicroinjected into
the rostral VLM. The brainstem was then rapidly removed and ﬁxed by
immersion for 5 days in 10% buffered formalin. Serial transverse
sections of 18 μm were cut using a cryostat and stained with cresyl
violet using the Nissl method. To conﬁrm that the microinjections were
delivered to the rostral VLM, the coronal brainstem sections of each rat
were analyzed by optical microscopy.2.7. Western blot
Separate groups of CIH (n=24) and control animals (n=24) were
deeply anesthetizedwith halothane; animals were decapitated to rapidly
remove the brain. The brainstem was frozen in dry ice; using a cryostat,
slices of 900-μm thicknesswere performed 1.2 mm rostral to the calamus
scriptorius andprepared to obtain 1 mmdiameter bilateral punches of the
VLMwhich contains pre-sympathetic neurons and respiratory neurons of
BötC/pre-BötC (Paxinos andWatson, 1998). Punches from3animalswere
pooled; chopped on ice using a pestle with 1 mL of lysis buffer (Hepes
50 mM; NaCl 150 mM; MgCl2 2 mM; EGTA 1mM; Triton 1%; Glycerol
10%, pH 7.4) plus 52 mg/mL phenylmethanesulfonyl ﬂuoride. The
homogenate was incubated for 30 min at 4 °C, followed by a 15 min
centrifugation at 15,000 g at 4 °C. Supernatants were separated and
stored at−20 °C. The total protein for each samplewas determinedusing
the BCA protein assay kit (Amersham Biosciences, Piscataway, NJ). Ten
micrograms of protein fromeach sample (pool of 3 animal samples)were
denatured and separated by SDS-PAGE 10% in Tris–glycine buffer. The
electrophoresed proteins were blotted onto PVDF membranes (Thermo
Scientiﬁc, Rockford, USA) and incubated with rabbit anti-NMDAR1
(1:2000), rabbit anti-GluR2/3 (1:1000), rabbit anti-P2X1 (1:1000), goat
anti-P2X3 (1:500), goat anti-P2X4 (1:500), goat-P2Y2 (1:1000) ormouse
anti-α-tubulin (1:15,000) antibodies. The immunoreacive bands were
visualized by incubation with the horseradish peroxidase-conjugated
with anti-rabbit (1:5000), anti-goat (1:5000), or anti-mouse IgG
(1:5000), which were detected using a enhanced chemiluminescence
(Super Signal, Thermo Scientiﬁc) and a radiographic ﬁlm (Hyperﬁlm ECL,
Amersham). Immunoreactive bands were quantiﬁed by densitometry
using the NIH Image J 1.40 software (National Institute of Health,2 s
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Fig. 1. Sympathetic and respiratory evoked responses to microinjections of L-glutamate and A
thoracic sympathetic (tSN), abdominal (Abd) and phrenic (PN) nerve activities from a repre
microinjections of 3 mM glutamate (panel A, arrows) or 10 mM ATP (panel B, arrows) intoUSA; http://rsbweb.nih.gov/ij/). Relative amounts of P2X1, P2X3,
P2X4, P2Y2, NMDAR1 and GluR2/3 detected were normalized with
respect to α-tubulin and expressed in arbitrary units (au).2.8. Statistical analyses
The results were expressed as mean±standard error and compared
using two-way ANOVA followed by Bonferroni post-hoc or Student's
unpaired t test. The comparisons were carried out on GraphPad Prism
software (GraphPadSoftware, version4) anddifferenceswere considered
signiﬁcant at Pb0.05.2.9. Drugs and providers
All the drugs and salts for buffers were purchased from Sigma
(St Louis, MO, USA). Antibodies were obtained from Calbiochem (La
Jolla, USA; anti-NMDAR1), Chemicon International (Temecula, USA;
anti-GluR2/3), Santa Cruz Biotechnologies (Santa Cruz, USA; anti-P2X1,
anti-P2X3, anti-P2X4, anti-P2Y2, anti-rabbit, anti-goat and anti-mouse
IgG) and Sigma (anti-α-tubulin).3. Results
3.1. Microinjections of L-glutamate into the VLM
L-glutamate microinjections into the rostral VLM increased tSN and
Abd activities and evoked a small reduction in phrenic burst frequency
in CIH and control groups (Fig. 1A). The magnitude of the 3 mM
glutamate-evoked abdominal (109±23 vs 93±16%, Fig. 2A1) and
sympathetic excitatory responses (76±7 vs77±12%, Fig. 3A) aswell as
the phrenic inhibitory responses (−24.6±4.4 vs −30.0±5.3%,
Fig. 2A2) were similar between CIH (n=10) and the controls (n=6).
Likewise, the magnitude of phrenic inhibitory responses elicited by
1 (−33.2±2.1 vs −32.5±2.9%) or 10 mM (−21.2±9.1 vs −34.4±
5.9%) L-glutamate, as well as the associated sympatho-excitatory
responses elicited by 1 mM (71±12 vs 47±9%) or 10 mM (98±12
vs74±10%, Fig. 3A),werenot differentbetweenCIH (n=4) andcontrol
rats (n=5). Microinjection sites were histologically conﬁrmed (Fig. 4).2 s
PN
PN
Abd
tSN
tSN
Control CIHB
ATP
(10 mM)
ATP
(10 mM)
Abd
TP into the rostral ventrolateral medulla of control and CIH rats. Raw and integrated (∫)
sentative control and CIH rat. Recordings illustrate the pattern of responses evoked by
the rostral VLM.
Control CIH
0
50
100
150
200
250
300
0 3 6 9 12 15 18 21 24 27 30
0
25
50
75
100
125
150
175
Control CIH
*
#
Time (s)
PN
 fr
eq
ue
nc
y 
(%
)
Control CIH
0
25
50
75
100
125
150 A1 A2
B1 B2
0 3 6 9 12 15 18 21 24 27 30
0
25
50
75
100
125
150
175
Control CIH
Time (s)
PN
 fr
eq
ue
nc
y 
(%
)
L-glu 3 mM
ATP 10 mM 
Fig. 2. Respiratory responses induced by microinjections of L-glutamate and ATP into the rostral ventrolateral medulla of CIH and control rats. Average percentual increase in
abdominal motor nerve (left panels) and time-course of phrenic inhibitory responses (right panels) induced by L-glutamate 3 mM (panels A1 and A2) or ATP 10 mM (panel B1 and
B2) into the rostral VLM of control (n=6 or 7, respectively L-glutamate and ATP) and CIH rats (n=10 or 8, respectively L-glutamate and ATP). Time 0 in panels A2 and B2, indicate the
microinjection. #, Pb0.05 as compared to the control group response.
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ATP produced excitation of tSN and Abd activities associated with an
inhibition of phrenic burst discharges in both CIH (n=8) and control rats
(n=7) (Fig. 1B) when injected into the rostral VLM. The magnitude of
the Abd response induced by 1 (219±72 vs 131±33%), 10 (223±45 vs
226±52%; Fig. 2B1) or 50 mM ATP (455±86 vs 325±95%) was similar
within groups. Likewise, the magnitude of phrenic frequency reduction
was not different between CIH and controls at the ATP concentrations
examined (1 mM:−13.7±7.6 vs−4.2±8.7%; 10 mM:−36.7±11.4 vs
−31.3±10.3%; 50 mM:−46.6±2.7 vs−42.2±6.1%). Notwithstanding,
an earlier recovery of the ATP-induced apneic responses was observed in
CIH rats as compared to controls (Pb0.05, Fig. 2B2). In contrast, the
sympatho-excitatory responses evoked by 1 mM (71±11 vs 41±4%,
Pb0.05) or 10 mM (119±17 vs 69±7%, Pb0.05), but not 50 mM of ATP
(138±12 vs 110±20%), were signiﬁcantly larger in CIH rats than in the
controls (Fig. 3B). The sites of ATP microinjections in the VLM were also
histologically conﬁrmed and are illustrated in Fig. 4.
3.3. CIH selectively increased P2X3 and P2X4 receptor immunoreactivity
in the VLM
Bands that correspond to glutamatergic receptors were observed
at 110 kDa in VLM samples. The intensity of NMDAR1 (1.17±0.07 vs
1.19±0.15 a.u.) and GluR2/3 bands (1.32±0.11 vs 1.57±0.13 a.u., CIH
and control groups respectively) did not differ between CIH (n=4) and
controls (n=4, Fig. 3C), suggesting that the density of these
glutamatergic receptor subunities were not altered in the VLM after
CIH. Moreover, well-deﬁned bands at approximately 55 kDa identiﬁed
the P2X1, P2X3, P2X4 and P2Y2 receptors in the VLM. The intensity of
the P2X1 receptor immunoreactivity did not differ between CIH (n=8)
and control rats (n=5) [0.88±0.03 vs 0.92±0.05 a.u.]; nor the P2Y2
receptor bands [0.70±0.05 vs 0.59±0.04 a.u.; in CIH (n=7) andcontrols (n=7) respectively]. In contrast, CIH signiﬁcantly increased, by
approximately 20%, the intensity of the bands corresponding to the
P2X3 [0.92±0.03 (n=8) vs 0.79±0.05 a.u. (n=8), P=0.0497] and
the P2X4 receptor [0.93±0.01 (n=3) vs 0.77±0.04 (n=3)a.u.;
P=0.0152]. Representative blots and the statistics of these results are
shown in Fig. 3D. We conclude that CIH selectively increased the
immunoreactivity for P2X3 and P2X4 receptors in the VLM, suggesting a
functional relationship between CIH and the immunoreactive levels
found for these particular purinoceptors in this brain area.
4. Discussion
In the present study, we veriﬁed that ATP and L-glutamate
microinjections into the VLM of juvenile rats evoked excitatory effects
on pre-sympathetic and expiratory neurons, eliciting increases of
sympathetic activity combined with excitation of abdominal motor
activity and inhibition of phrenic bursts. Concurrently, an increased
P2X3 and P2X4 receptor immunoreactivity was observed in the VLM
of CIH rats, which agrees with the functional observations that ATP
microinjections in the VLM of CIH rats elicited larger sympatho-
excitatory responses. In contrast, neither L-glutamate-evoked re-
sponses nor the immunoreactive density of glutamatergic receptors
were modiﬁed by CIH, suggesting that CIH increased purinergic
signaling in the VLM, affecting pre-sympathetic neurons controlling
efferent sympathetic activity in juvenile rats.
L-glutamate is a major excitatory neurotransmitter acting on pre-
sympathetic neurons of VLM and on expiratory and inspiratory
neurons of BötC and pre-BötC, respectively (Bianchi et al., 1995;
Dampney et al., 2003). Studies performed in anesthetized animals
reported that L-glutamate microinjections in the VLM caused
sympatho-excitation (Ross et al., 1984) associated with either phrenic
inhibition at the level of BötC (Chitravanshi and Sapru, 1999; Monnier
et al., 2003) or phrenic and hypoglossal excitation in the pre-BötC area
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Fig. 3. Sympatho-excitatory responses induced by L-glutamate or ATP and density of glutamatergic and purinergic receptors in the rostral ventrolateral medulla of control and CIH
rats. Upper panels: Average percentual increase in thoracic sympathetic nerve activity (Δ tSN) in response to microinjections of different concentrations of L-glutamate (panel A) or
ATP (panel B) into the rostral VLM of control (n=5–6 or 7, respectively L-glutamate and ATP) and CIH rats (n=4–10 or 8, respectively L-glutamate and ATP). *, Pb0.05 — as
compared to the corresponding control group response. Lower panels: Representative immunoreactive bands of NMDA R1 and GluR 2/3 receptor subunities (panel C) or P2X1, P2X3,
P2X4 and P2Y2 receptors (panel D) in the ventrolateral medulla of control (n=4 or 3–8, respectively L-glutamate and ATP) and CIH rats (n=4 or 3–8, respectively L-glutamate and
ATP) and their relation with the α-tubulin band (bar graphs). *, Pb0.05 as compared to the corresponding control group.
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present study, we veriﬁed that L-glutamate microinjections into the
VLM (caudal to facial nucleus) of unanesthetized in situ preparations
elicited sympatho-excitatory and phrenic inhibitory responses asso-
ciated with an increase in abdominal motor activity. These data are
consistent with the notion that our L-glutamate microinjections were
performed at the level of the BötC expiratory neurons. The excitation
of these expiratory neurons was important not only to produce the
inhibition of inspiratory neurons of VRC (Tian et al., 1999; Ezure et al.,py
BötC
RVLM
bas
NA
bas
NA
Fig. 4. Histological analysis conﬁrming the microinjections sites of L-glutamate and ATP in th
coronal sections from a control (upper panels) and a CIH rat (bottom panels), combined wit
rostral VLM (left panels) and the approximate center of microinjections of all animals (rig
rostral ventrolateral medulla; bas: basilar artery; py: pyramidal tract.2003; Smith et al., 2007) and cause phrenic inhibition, but also to
excite the bulbo-spinal expiratory neurons of the caudal VRC, either
by interneuron pathways (Molkov et al., 2010) or even directly (Ezure
et al., 2003), and increase the abdominal activity. With respect to the
responses observed in the CIH group, the evoked sympathetic and
respiratory alterations induced by L-glutamate microinjections into
the VLM were similar to those observed in the control group. In
addition, western blot analysis showed that the density of either
NMDAR1 or GluR2/3 glutamatergic receptor subunities in the VLMNA
py
NA
BötC
RVLM
Control
CIH
e rostral ventrolateral medulla of control and CIH rats. Photomicrographs of brainstem
h schematic drawings from Paxinos and Watson (1998), showing the dye marker in the
ht panels). Scale bar: 500 μm. NA: nucleus ambigus; BötC: Bötzinger complex; RVLM:
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ionotropic glutamatergic signaling may not be altered by CIH in the
VLM of juvenile rats.
Accumulating experimental evidence points to a role for ATP, acting
onP2XandP2Y receptors, in the control of sympathetic (Sun et al., 1992;
Ralevic et al., 1999) and respiratory activities (Thomas et al., 2001;
Huxtable et al., 2009). The present ﬁndings that microinjections of ATP
into the rostral VLM of in situ preparations increased sympathetic
activity and inhibited phrenic discharges agree with previous studies
performed in anesthetized animals (Thomas et al., 2001) and show that
ATP has an excitatory role on BötC neurons. The later, in turn, would
produce the inhibition on inspiratory neurons and the excitation of
bulbo-spinal expiratory caudal toVRCneurons, eliciting the responsesof
phrenic inhibition and abdominal excitation, as discussed in a previous
paragraph.We have not ignored the possible contribution of adenosine,
an active ATPmetabolite, on the respiratory and sympathetic responses
to microinjection of ATP into rostral VLM. Although we did not conduct
experiments with adenosine receptor antagonists to preclude this
possibility, we veriﬁed that rostral VLMmicroinjections of α,β,methyl-
ATP, a non-hydrolysable purinergic receptor agonist, evoked similar
patterns of respiratory and sympathetic responses as those elicited by
ATP (data not shown). Moreover, adenosine applications in the VLM
either increased or decreased arterial pressure (Thomas and Spyer,
1996) as well as depressed the respiratory neuronal activity (Vandam
et al., 2008), a ﬁnding that strongly suggests that the ATP-induced
responses in the rostral VLM were mainly related to P2 receptor
activation.
In CIH rats, we veriﬁed that the abdominal and phrenic responses
evoked by ATP in the VLM were similar in magnitude to the control
group. On the other hand, ATP-induced sympatho-excitatory re-
sponses were higher in the VLM of CIH rats than of controls.
Consonant with increased functional responses, we observed a 20%
increase in the P2X3 and P2X4 receptor immunoreactivity, evidencing
a relationship between a higher sympatho-excitatory response and an
augmented density of receptors. Altogether, these data strongly
indicate that purinergic signaling is up-regulated in the rostral aspect
of VLM. It would be exciting to examine the respiratory and
sympathetic effects of P2X3 and P2X4 antagonists in the VLM of rats
during CIH exposure; however, the lack of selective P2X receptor
subtype antagonists (Burnstock, 2007), will not allow interpreting
correctly results derived from these protocols. In addition, there is
scarce information available about the effective dose and blood brain
barrier penetration of P2 receptors antagonists for in-vivo studies
during CIH exposure, or the antagonist diffusion rates for acute brain
microinjection protocols. Considering these strong limitations, we
deemed not advisable to run antagonism experiments until more
speciﬁc compounds become available and there is a clearer notion of
the pharmacokinetics of these antagonists for in vivo studies.
P2 receptors are abundantly expressed in the brain and have a role
on purinergic transmission acting both pre- and post-junctionally
(Burnstock, 2007). Immuno-histochemical and pharmacological studies
demonstrate that P2X receptors play an excitatory role on pre-
sympathetic VLMneurons (Sun et al., 1992; Ralevic et al., 1999; Thomas
et al., 2001). The ﬁnding that the immunoreactive density of P2X3 and
P2X4 receptors increased, while the P2X1 receptor was notmodiﬁed by
CIH is intriguing. Studies demonstrate that P2X3, or its P2X2/3
heteromeric form, are involved in the hypoxia-induced signaling in
the carotid bodies (Prasad et al., 2001). As far as at the central nervous
system P2X3 receptors are mostly found in the brainstem (Burnstock,
2007), this receptor subtypemay be also important for VLM processing
of chemoreﬂex-evoked responses, which might explain the selectivity
of its alteration following CIH. In addition, Cavaliere et al. (2003)
reported that in ischemia, the expression of P2X2 and P2X4 receptors
is increased in the hippocampus, which indicates that hypoxia
may modulate the expression of these receptors, and possibly their
heteromeric forms.Our ﬁndings are showing that the immunoreactivity of P2X3 and
P2X4 receptors, but not other P2X or P2Y receptors, increased in the
VLM of CIH rats, agreeing with the hypothesis that these receptors are
importantmediators of ATP-dependent responses evoked byhypoxia as
well as this stimulusmaymodulate their expression. Several hypotheses
might be raised to explain the increased immunoreactivity of P2X3 and
P2X4 receptors. Amongothers, an increase rate of receptor synthesis, an
increased stability of themRNAcoding for these receptors or a reduction
in its degradation rate during CIH, might account for the increase in the
receptor bands observed. Speciﬁc experiments need to be designed to
distinguish between these alternatives. Notwithstanding, our data
suggest that the enhanced P2X3 and P2X4 receptor density is functional
since CIH increased the ATP responses of the pre-sympathetic VLM
neurons, but not the respiratory neurons of BötC. The shorter apneic
response to microinjections of ATP into the VLM in CIH rats might be
associated with a possible faster rate of ATP metabolism at the VLM of
rats submitted to CIH. Alternatively, it is also possible that inspiratory
neurons in the vicinity of the sites of ATPmicroinjections, such as those
fromthepre-BötC (Sunet al., 1998; Lorier et al., 2007),maybealteredby
CIH and activated by the ATP spread from the center of microinjection,
contributing to the pattern of response observed in CIH. Additional
experiments are needed to resolve these issues.
In summary, CIH enhanced sympatho-excitatory response to ATP
microinjections into the VLM, possibly related to a speciﬁc increase in
P2X3 and P2X4 receptor density in the VLM. In contrast, CIH does not
affect glutamatergic signaling in the VLM of juvenile rats, revealing
that CIH modiﬁed preferentially only some brain networks operating
at the VLM. At present we cannot rule out the possibility that tonic
glutamatergic transmission in VLM neurons of CIH rats is also
modiﬁed, especially considering studies showing that the activation
of pre-synaptic P2X3 and P2X2/3 agonists increase glutamatergic
transmission on trigeminal neurons (Jennings et al., 2006). Moreover,
it has been recently described an important network involving L-
glutamate, ATP, glial cells that modulate the neuronal activity in some
brain regions, including the ventrolateral medulla (Huxtable et al.,
2010). The mechanisms that account for the increased purinergic
signaling as well as the possible interaction between purinergic and
glutamatergic mechanisms of the VLM in the respiratory and
sympathetic alterations observed in CIH juvenile rats are matters for
further investigations. The neurochemical and cell biology basis of
how CIH triggers these unambiguous changes in the VLM neuronal
network of juvenile rats warrants expanding our investigations. In
this regard, it is of interest examining whether the expression of P2X3
and P2X4 receptors are controlled by transcriptional factors, including
hypoxia induced factors (HIF-1 and HIF-2) which are known to be
modulated in CIH (Nanduri et al., 2008; Prabhakar et al., 2009).
Moreover, it will be important to analyze the role of the cell red-ox
status and its regulation by HIF-1 and HIF-2, novel variables that are
recently known to be critically involved in hypoxia (Prabhakar et al.,
2009). Concomitantly, CIH may also directly or indirectly modify the
release of ATP from purinergic pathways, inﬂuencing therefore the
synaptic strength of VLM pathways. At the light of these novel
observations, implying an increased purinergic transmission in CIH,
related to increased functional sympatho-excitation responses, the
understanding of the neurochemical mechanisms underlying hyper-
tension in patients suffering from OSA might be clinically relevant.Acknowledgements
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